Biosimilars Market - Global Outlook and Forecast 2021-2027

Biosimilars Market - Global Outlook and Forecast 2021-2027

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Biosimilars Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Biosimilars Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Biosimilars Overall Market Size
2.1 Global Biosimilars Market Size: 2021 VS 2027
2.2 Global Biosimilars Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Biosimilars Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Biosimilars Players in Global Market
3.2 Top Global Biosimilars Companies Ranked by Revenue
3.3 Global Biosimilars Revenue by Companies
3.4 Global Biosimilars Sales by Companies
3.5 Global Biosimilars Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Biosimilars Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Biosimilars Product Type
3.8 Tier 1, Tier 2 and Tier 3 Biosimilars Players in Global Market
3.8.1 List of Global Tier 1 Biosimilars Companies
3.8.2 List of Global Tier 2 and Tier 3 Biosimilars Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Biosimilars Market Size Markets, 2021 & 2027
4.1.2 Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
4.1.3 Recombinant Glycosylated Proteins
4.2 By Type - Global Biosimilars Revenue & Forecasts
4.2.1 By Type - Global Biosimilars Revenue, 2016-2021
4.2.2 By Type - Global Biosimilars Revenue, 2022-2027
4.2.3 By Type - Global Biosimilars Revenue Market Share, 2016-2027
4.3 By Type - Global Biosimilars Sales & Forecasts
4.3.1 By Type - Global Biosimilars Sales, 2016-2021
4.3.2 By Type - Global Biosimilars Sales, 2022-2027
4.3.3 By Type - Global Biosimilars Sales Market Share, 2016-2027
4.4 By Type - Global Biosimilars Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Biosimilars Market Size, 2021 & 2027
5.1.2 Oncology
5.1.3 Blood Disorders
5.1.4 Growth Hormonal Deficiency
5.1.5 Chronic and Autoimmune Disorders
5.1.6 Others
5.2 By Application - Global Biosimilars Revenue & Forecasts
5.2.1 By Application - Global Biosimilars Revenue, 2016-2021
5.2.2 By Application - Global Biosimilars Revenue, 2022-2027
5.2.3 By Application - Global Biosimilars Revenue Market Share, 2016-2027
5.3 By Application - Global Biosimilars Sales & Forecasts
5.3.1 By Application - Global Biosimilars Sales, 2016-2021
5.3.2 By Application - Global Biosimilars Sales, 2022-2027
5.3.3 By Application - Global Biosimilars Sales Market Share, 2016-2027
5.4 By Application - Global Biosimilars Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Biosimilars Market Size, 2021 & 2027
6.2 By Region - Global Biosimilars Revenue & Forecasts
6.2.1 By Region - Global Biosimilars Revenue, 2016-2021
6.2.2 By Region - Global Biosimilars Revenue, 2022-2027
6.2.3 By Region - Global Biosimilars Revenue Market Share, 2016-2027
6.3 By Region - Global Biosimilars Sales & Forecasts
6.3.1 By Region - Global Biosimilars Sales, 2016-2021
6.3.2 By Region - Global Biosimilars Sales, 2022-2027
6.3.3 By Region - Global Biosimilars Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Biosimilars Revenue, 2016-2027
6.4.2 By Country - North America Biosimilars Sales, 2016-2027
6.4.3 US Biosimilars Market Size, 2016-2027
6.4.4 Canada Biosimilars Market Size, 2016-2027
6.4.5 Mexico Biosimilars Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Biosimilars Revenue, 2016-2027
6.5.2 By Country - Europe Biosimilars Sales, 2016-2027
6.5.3 Germany Biosimilars Market Size, 2016-2027
6.5.4 France Biosimilars Market Size, 2016-2027
6.5.5 U.K. Biosimilars Market Size, 2016-2027
6.5.6 Italy Biosimilars Market Size, 2016-2027
6.5.7 Russia Biosimilars Market Size, 2016-2027
6.5.8 Nordic Countries Biosimilars Market Size, 2016-2027
6.5.9 Benelux Biosimilars Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Biosimilars Revenue, 2016-2027
6.6.2 By Region - Asia Biosimilars Sales, 2016-2027
6.6.3 China Biosimilars Market Size, 2016-2027
6.6.4 Japan Biosimilars Market Size, 2016-2027
6.6.5 South Korea Biosimilars Market Size, 2016-2027
6.6.6 Southeast Asia Biosimilars Market Size, 2016-2027
6.6.7 India Biosimilars Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Biosimilars Revenue, 2016-2027
6.7.2 By Country - South America Biosimilars Sales, 2016-2027
6.7.3 Brazil Biosimilars Market Size, 2016-2027
6.7.4 Argentina Biosimilars Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Biosimilars Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Biosimilars Sales, 2016-2027
6.8.3 Turkey Biosimilars Market Size, 2016-2027
6.8.4 Israel Biosimilars Market Size, 2016-2027
6.8.5 Saudi Arabia Biosimilars Market Size, 2016-2027
6.8.6 UAE Biosimilars Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Biosimilars Major Product Offerings
7.1.4 Pfizer Biosimilars Sales and Revenue in Global (2016-2021)
7.1.5 Pfizer Key News
7.2 Novartis
7.2.1 Novartis Corporate Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Biosimilars Major Product Offerings
7.2.4 Novartis Biosimilars Sales and Revenue in Global (2016-2021)
7.2.5 Novartis Key News
7.3 Biocon
7.3.1 Biocon Corporate Summary
7.3.2 Biocon Business Overview
7.3.3 Biocon Biosimilars Major Product Offerings
7.3.4 Biocon Biosimilars Sales and Revenue in Global (2016-2021)
7.3.5 Biocon Key News
7.4 Biogen
7.4.1 Biogen Corporate Summary
7.4.2 Biogen Business Overview
7.4.3 Biogen Biosimilars Major Product Offerings
7.4.4 Biogen Biosimilars Sales and Revenue in Global (2016-2021)
7.4.5 Biogen Key News
7.5 Fresenius Kabi AG
7.5.1 Fresenius Kabi AG Corporate Summary
7.5.2 Fresenius Kabi AG Business Overview
7.5.3 Fresenius Kabi AG Biosimilars Major Product Offerings
7.5.4 Fresenius Kabi AG Biosimilars Sales and Revenue in Global (2016-2021)
7.5.5 Fresenius Kabi AG Key News
7.6 Boehringer Ingelheim
7.6.1 Boehringer Ingelheim Corporate Summary
7.6.2 Boehringer Ingelheim Business Overview
7.6.3 Boehringer Ingelheim Biosimilars Major Product Offerings
7.6.4 Boehringer Ingelheim Biosimilars Sales and Revenue in Global (2016-2021)
7.6.5 Boehringer Ingelheim Key News
7.7 Merck KgaA
7.7.1 Merck KgaA Corporate Summary
7.7.2 Merck KgaA Business Overview
7.7.3 Merck KgaA Biosimilars Major Product Offerings
7.4.4 Merck KgaA Biosimilars Sales and Revenue in Global (2016-2021)
7.7.5 Merck KgaA Key News
7.8 Mylan
7.8.1 Mylan Corporate Summary
7.8.2 Mylan Business Overview
7.8.3 Mylan Biosimilars Major Product Offerings
7.8.4 Mylan Biosimilars Sales and Revenue in Global (2016-2021)
7.8.5 Mylan Key News
7.9 Eli Lilly
7.9.1 Eli Lilly Corporate Summary
7.9.2 Eli Lilly Business Overview
7.9.3 Eli Lilly Biosimilars Major Product Offerings
7.9.4 Eli Lilly Biosimilars Sales and Revenue in Global (2016-2021)
7.9.5 Eli Lilly Key News
7.10 Teva Pharmaceutical
7.10.1 Teva Pharmaceutical Corporate Summary
7.10.2 Teva Pharmaceutical Business Overview
7.10.3 Teva Pharmaceutical Biosimilars Major Product Offerings
7.10.4 Teva Pharmaceutical Biosimilars Sales and Revenue in Global (2016-2021)
7.10.5 Teva Pharmaceutical Key News
7.11 Dr. Reddy's Laboratories
7.11.1 Dr. Reddy's Laboratories Corporate Summary
7.11.2 Dr. Reddy's Laboratories Biosimilars Business Overview
7.11.3 Dr. Reddy's Laboratories Biosimilars Major Product Offerings
7.11.4 Dr. Reddy's Laboratories Biosimilars Sales and Revenue in Global (2016-2021)
7.11.5 Dr. Reddy's Laboratories Key News
7.12 Amgen
7.12.1 Amgen Corporate Summary
7.12.2 Amgen Biosimilars Business Overview
7.12.3 Amgen Biosimilars Major Product Offerings
7.12.4 Amgen Biosimilars Sales and Revenue in Global (2016-2021)
7.12.5 Amgen Key News
7.13 Celltrion
7.13.1 Celltrion Corporate Summary
7.13.2 Celltrion Biosimilars Business Overview
7.13.3 Celltrion Biosimilars Major Product Offerings
7.13.4 Celltrion Biosimilars Sales and Revenue in Global (2016-2021)
7.13.5 Celltrion Key News
7.14 Samsung Biologics
7.14.1 Samsung Biologics Corporate Summary
7.14.2 Samsung Biologics Business Overview
7.14.3 Samsung Biologics Biosimilars Major Product Offerings
7.14.4 Samsung Biologics Biosimilars Sales and Revenue in Global (2016-2021)
7.14.5 Samsung Biologics Key News
7.15 Roche
7.15.1 Roche Corporate Summary
7.15.2 Roche Business Overview
7.15.3 Roche Biosimilars Major Product Offerings
7.15.4 Roche Biosimilars Sales and Revenue in Global (2016-2021)
7.15.5 Roche Key News
7.16 Probiomed
7.16.1 Probiomed Corporate Summary
7.16.2 Probiomed Business Overview
7.16.3 Probiomed Biosimilars Major Product Offerings
7.16.4 Probiomed Biosimilars Sales and Revenue in Global (2016-2021)
7.16.5 Probiomed Key News
7.17 Apotex
7.17.1 Apotex Corporate Summary
7.17.2 Apotex Business Overview
7.17.3 Apotex Biosimilars Major Product Offerings
7.17.4 Apotex Biosimilars Sales and Revenue in Global (2016-2021)
7.17.5 Apotex Key News
7.18 Chong Kun Dang
7.18.1 Chong Kun Dang Corporate Summary
7.18.2 Chong Kun Dang Business Overview
7.18.3 Chong Kun Dang Biosimilars Major Product Offerings
7.18.4 Chong Kun Dang Biosimilars Sales and Revenue in Global (2016-2021)
7.18.5 Chong Kun Dang Key News
7.19 JCR Pharmaceuticals
7.19.1 JCR Pharmaceuticals Corporate Summary
7.19.2 JCR Pharmaceuticals Business Overview
7.19.3 JCR Pharmaceuticals Biosimilars Major Product Offerings
7.19.4 JCR Pharmaceuticals Biosimilars Sales and Revenue in Global (2016-2021)
7.19.5 JCR Pharmaceuticals Key News
7.20 Gan & Lee Pharmaceuticals
7.20.1 Gan & Lee Pharmaceuticals Corporate Summary
7.20.2 Gan & Lee Pharmaceuticals Business Overview
7.20.3 Gan & Lee Pharmaceuticals Biosimilars Major Product Offerings
7.20.4 Gan & Lee Pharmaceuticals Biosimilars Sales and Revenue in Global (2016-2021)
7.20.5 Gan & Lee Pharmaceuticals Key News
7.21 Gedeon Richter
7.21.1 Gedeon Richter Corporate Summary
7.21.2 Gedeon Richter Business Overview
7.21.3 Gedeon Richter Biosimilars Major Product Offerings
7.21.4 Gedeon Richter Biosimilars Sales and Revenue in Global (2016-2021)
7.21.5 Gedeon Richter Key News
7.22 Biocad
7.22.1 Biocad Corporate Summary
7.22.2 Biocad Business Overview
7.22.3 Biocad Biosimilars Major Product Offerings
7.22.4 Biocad Biosimilars Sales and Revenue in Global (2016-2021)
7.22.5 Biocad Key News
7.23 Coherus Bioscience
7.23.1 Coherus Bioscience Corporate Summary
7.23.2 Coherus Bioscience Business Overview
7.23.3 Coherus Bioscience Biosimilars Major Product Offerings
7.23.4 Coherus Bioscience Biosimilars Sales and Revenue in Global (2016-2021)
7.23.5 Coherus Bioscience Key News
7.24 Stada Arzneimittel AG
7.24.1 Stada Arzneimittel AG Corporate Summary
7.24.2 Stada Arzneimittel AG Business Overview
7.24.3 Stada Arzneimittel AG Biosimilars Major Product Offerings
7.24.4 Stada Arzneimittel AG Biosimilars Sales and Revenue in Global (2016-2021)
7.24.5 Stada Arzneimittel AG Key News
8 Global Biosimilars Production Capacity, Analysis
8.1 Global Biosimilars Production Capacity, 2016-2027
8.2 Biosimilars Production Capacity of Key Manufacturers in Global Market
8.3 Global Biosimilars Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Biosimilars Supply Chain Analysis
10.1 Biosimilars Industry Value Chain
10.2 Biosimilars Upstream Market
10.3 Biosimilars Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Biosimilars Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Biosimilars in Global Market
Table 2. Top Biosimilars Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Biosimilars Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Biosimilars Revenue Share by Companies, 2016-2021
Table 5. Global Biosimilars Sales by Companies, (K MT), 2016-2021
Table 6. Global Biosimilars Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Biosimilars Price (2016-2021) & (USD/MT)
Table 8. Global Manufacturers Biosimilars Product Type
Table 9. List of Global Tier 1 Biosimilars Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Biosimilars Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Biosimilars Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Global Biosimilars Revenue (US$, Mn), 2016-2021
Table 13. By Type - Global Biosimilars Revenue (US$, Mn), 2022-2027
Table 14. By Type - Global Biosimilars Sales (K MT), 2016-2021
Table 15. By Type - Global Biosimilars Sales (K MT), 2022-2027
Table 16. By Application - Global Biosimilars Revenue, (US$, Mn), 2021 VS 2027
Table 17. By Application - Global Biosimilars Revenue (US$, Mn), 2016-2021
Table 18. By Application - Global Biosimilars Revenue (US$, Mn), 2022-2027
Table 19. By Application - Global Biosimilars Sales (K MT), 2016-2021
Table 20. By Application - Global Biosimilars Sales (K MT), 2022-2027
Table 21. By Region - Global Biosimilars Revenue, (US$, Mn), 2021 VS 2027
Table 22. By Region - Global Biosimilars Revenue (US$, Mn), 2016-2021
Table 23. By Region - Global Biosimilars Revenue (US$, Mn), 2022-2027
Table 24. By Region - Global Biosimilars Sales (K MT), 2016-2021
Table 25. By Region - Global Biosimilars Sales (K MT), 2022-2027
Table 26. By Country - North America Biosimilars Revenue, (US$, Mn), 2016-2021
Table 27. By Country - North America Biosimilars Revenue, (US$, Mn), 2022-2027
Table 28. By Country - North America Biosimilars Sales, (K MT), 2016-2021
Table 29. By Country - North America Biosimilars Sales, (K MT), 2022-2027
Table 30. By Country - Europe Biosimilars Revenue, (US$, Mn), 2016-2021
Table 31. By Country - Europe Biosimilars Revenue, (US$, Mn), 2022-2027
Table 32. By Country - Europe Biosimilars Sales, (K MT), 2016-2021
Table 33. By Country - Europe Biosimilars Sales, (K MT), 2022-2027
Table 34. By Region - Asia Biosimilars Revenue, (US$, Mn), 2016-2021
Table 35. By Region - Asia Biosimilars Revenue, (US$, Mn), 2022-2027
Table 36. By Region - Asia Biosimilars Sales, (K MT), 2016-2021
Table 37. By Region - Asia Biosimilars Sales, (K MT), 2022-2027
Table 38. By Country - South America Biosimilars Revenue, (US$, Mn), 2016-2021
Table 39. By Country - South America Biosimilars Revenue, (US$, Mn), 2022-2027
Table 40. By Country - South America Biosimilars Sales, (K MT), 2016-2021
Table 41. By Country - South America Biosimilars Sales, (K MT), 2022-2027
Table 42. By Country - Middle East & Africa Biosimilars Revenue, (US$, Mn), 2016-2021
Table 43. By Country - Middle East & Africa Biosimilars Revenue, (US$, Mn), 2022-2027
Table 44. By Country - Middle East & Africa Biosimilars Sales, (K MT), 2016-2021
Table 45. By Country - Middle East & Africa Biosimilars Sales, (K MT), 2022-2027
Table 46. Pfizer Corporate Summary
Table 47. Pfizer Biosimilars Product Offerings
Table 48. Pfizer Biosimilars Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 49. Novartis Corporate Summary
Table 50. Novartis Biosimilars Product Offerings
Table 51. Novartis Biosimilars Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 52. Biocon Corporate Summary
Table 53. Biocon Biosimilars Product Offerings
Table 54. Biocon Biosimilars Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 55. Biogen Corporate Summary
Table 56. Biogen Biosimilars Product Offerings
Table 57. Biogen Biosimilars Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 58. Fresenius Kabi AG Corporate Summary
Table 59. Fresenius Kabi AG Biosimilars Product Offerings
Table 60. Fresenius Kabi AG Biosimilars Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 61. Boehringer Ingelheim Corporate Summary
Table 62. Boehringer Ingelheim Biosimilars Product Offerings
Table 63. Boehringer Ingelheim Biosimilars Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 64. Merck KgaA Corporate Summary
Table 65. Merck KgaA Biosimilars Product Offerings
Table 66. Merck KgaA Biosimilars Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 67. Mylan Corporate Summary
Table 68. Mylan Biosimilars Product Offerings
Table 69. Mylan Biosimilars Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 70. Eli Lilly Corporate Summary
Table 71. Eli Lilly Biosimilars Product Offerings
Table 72. Eli Lilly Biosimilars Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 73. Teva Pharmaceutical Corporate Summary
Table 74. Teva Pharmaceutical Biosimilars Product Offerings
Table 75. Teva Pharmaceutical Biosimilars Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 76. Dr. Reddy's Laboratories Corporate Summary
Table 77. Dr. Reddy's Laboratories Biosimilars Product Offerings
Table 78. Dr. Reddy's Laboratories Biosimilars Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 79. Amgen Corporate Summary
Table 80. Amgen Biosimilars Product Offerings
Table 81. Amgen Biosimilars Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 82. Celltrion Corporate Summary
Table 83. Celltrion Biosimilars Product Offerings
Table 84. Celltrion Biosimilars Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 85. Samsung Biologics Corporate Summary
Table 86. Samsung Biologics Biosimilars Product Offerings
Table 87. Samsung Biologics Biosimilars Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 88. Roche Corporate Summary
Table 89. Roche Biosimilars Product Offerings
Table 90. Roche Biosimilars Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 91. Probiomed Corporate Summary
Table 92. Probiomed Biosimilars Product Offerings
Table 93. Probiomed Biosimilars Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 94. Apotex Corporate Summary
Table 95. Apotex Biosimilars Product Offerings
Table 96. Apotex Biosimilars Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 97. Chong Kun Dang Corporate Summary
Table 98. Chong Kun Dang Biosimilars Product Offerings
Table 99. Chong Kun Dang Biosimilars Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 100. JCR Pharmaceuticals Corporate Summary
Table 101. JCR Pharmaceuticals Biosimilars Product Offerings
Table 102. JCR Pharmaceuticals Biosimilars Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 103. Gan & Lee Pharmaceuticals Corporate Summary
Table 104. Gan & Lee Pharmaceuticals Biosimilars Product Offerings
Table 105. Gan & Lee Pharmaceuticals Biosimilars Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 106. Gedeon Richter Corporate Summary
Table 107. Gedeon Richter Biosimilars Product Offerings
Table 108. Gedeon Richter Biosimilars Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 109. Biocad Corporate Summary
Table 110. Biocad Biosimilars Product Offerings
Table 111. Biocad Biosimilars Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 112. Coherus Bioscience Corporate Summary
Table 113. Coherus Bioscience Biosimilars Product Offerings
Table 114. Coherus Bioscience Biosimilars Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 115. Stada Arzneimittel AG Corporate Summary
Table 116. Stada Arzneimittel AG Biosimilars Product Offerings
Table 117. Stada Arzneimittel AG Biosimilars Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 118. Biosimilars Production Capacity (K MT) of Key Manufacturers in Global Market, 2019-2021 (K MT)
Table 119. Global Biosimilars Capacity Market Share of Key Manufacturers, 2019-2021
Table 120. Global Biosimilars Production by Region, 2016-2021 (K MT)
Table 121. Global Biosimilars Production by Region, 2022-2027 (K MT)
Table 122. Biosimilars Market Opportunities & Trends in Global Market
Table 123. Biosimilars Market Drivers in Global Market
Table 124. Biosimilars Market Restraints in Global Market
Table 125. Biosimilars Raw Materials
Table 126. Biosimilars Raw Materials Suppliers in Global Market
Table 127. Typical Biosimilars Downstream
Table 128. Biosimilars Downstream Clients in Global Market
Table 129. Biosimilars Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Biosimilars Segment by Type
Figure 2. Biosimilars Segment by Application
Figure 3. Global Biosimilars Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Biosimilars Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Biosimilars Revenue, 2016-2027 (US$, Mn)
Figure 7. Biosimilars Sales in Global Market: 2016-2027 (K MT)
Figure 8. The Top 3 and 5 Players Market Share by Biosimilars Revenue in 2020
Figure 9. By Type - Global Biosimilars Sales Market Share, 2016-2027
Figure 10. By Type - Global Biosimilars Revenue Market Share, 2016-2027
Figure 11. By Type - Global Biosimilars Price (USD/MT), 2016-2027
Figure 12. By Application - Global Biosimilars Sales Market Share, 2016-2027
Figure 13. By Application - Global Biosimilars Revenue Market Share, 2016-2027
Figure 14. By Application - Global Biosimilars Price (USD/MT), 2016-2027
Figure 15. By Region - Global Biosimilars Sales Market Share, 2016-2027
Figure 16. By Region - Global Biosimilars Revenue Market Share, 2016-2027
Figure 17. By Country - North America Biosimilars Revenue Market Share, 2016-2027
Figure 18. By Country - North America Biosimilars Sales Market Share, 2016-2027
Figure 19. US Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 20. Canada Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 21. Mexico Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 22. By Country - Europe Biosimilars Revenue Market Share, 2016-2027
Figure 23. By Country - Europe Biosimilars Sales Market Share, 2016-2027
Figure 24. Germany Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 25. France Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 26. U.K. Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 27. Italy Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 28. Russia Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 29. Nordic Countries Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 30. Benelux Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 31. By Region - Asia Biosimilars Revenue Market Share, 2016-2027
Figure 32. By Region - Asia Biosimilars Sales Market Share, 2016-2027
Figure 33. China Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 34. Japan Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 35. South Korea Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 36. Southeast Asia Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 37. India Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 38. By Country - South America Biosimilars Revenue Market Share, 2016-2027
Figure 39. By Country - South America Biosimilars Sales Market Share, 2016-2027
Figure 40. Brazil Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 41. Argentina Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 42. By Country - Middle East & Africa Biosimilars Revenue Market Share, 2016-2027
Figure 43. By Country - Middle East & Africa Biosimilars Sales Market Share, 2016-2027
Figure 44. Turkey Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 45. Israel Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 46. Saudi Arabia Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 47. UAE Biosimilars Revenue, (US$, Mn), 2016-2027
Figure 48. Global Biosimilars Production Capacity (K MT), 2016-2027
Figure 49. The Percentage of Production Biosimilars by Region, 2020 VS 2027
Figure 50. Biosimilars Industry Value Chain
Figure 51. Marketing Channels

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Biologics and Biosimilars Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 147

According to our LPI (LP Information) latest study, the global Biologics and Biosimilars market size was valued at US$ 458090 million in 2023. With growing demand in downstream market, the Biologics and Biosimilars is forecast to a readjusted size of US$ 837640 million by 2030 with a CAGR of 9.0% during review period. The research report highlights the growth potential of the global Biologics and Biosimilars market. Biologics and Biosimilars are expected to show stable growth in the futu......

Global Biosimilar Drug Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94

According to our LPI (LP Information) latest study, the global Biosimilar Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the Biosimilar Drug is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Biosimilar Drug market. Biosimilar Drug are expected to show stable growth in the future market. However, product differentiation, reducing cost......

Global Biologics and Biosimilars Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 147

According to our (Global Info Research) latest study, the global Biologics and Biosimilars market size was valued at USD 481830 million in 2023 and is forecast to a readjusted size of USD 842330 million by 2030 with a CAGR of 8.3% during review period. Biologics are very specific, highly effective medicines made in living cells, and historically this was often an animal. Biologics include hormones, cytokines, growth factors, vaccines, gene and cellular therapies, fusion proteins, insulin......

Global Biosimilars Market Research Report 2023, Forecast to 2028

Published: 27-Dec-2023        Price: US 2680 Onwards        Pages: 167

A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......

Global Biosimilars Professional Survey Report 2023, Forecast to 2028

Published: 27-Dec-2023        Price: US 3280 Onwards        Pages: 133

A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......

Global Biosimilars Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 07-Dec-2023        Price: US 3380 Onwards        Pages: 106

Market Overview of Global Biosimilars market: According to our latest research, the global Biosimilars market looks promising in the next 5 years. As of 2022, the global Biosimilars market was estimated at USD 8203.97 million, and it's anticipated to reach USD 40650.01 million in 2028, with a CAGR of 30.57% during the forecast years. A biosimilar product is a biologic product that is approved based on demonstrating that it is highly similar to an FDA?approved biologic product......

Global Biologics and Biosimilars Professional Survey Report 2023, Forecast to 2028

Published: 24-Nov-2023        Price: US 3280 Onwards        Pages: 134

Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......

Global Biologics and Biosimilars Market Research Report 2023, Forecast to 2028

Published: 24-Nov-2023        Price: US 2680 Onwards        Pages: 160

Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......

Global Biosimilar Monoclonal Antibodies Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 103

Market Overview of Global Biosimilar Monoclonal Antibodies market: According to our latest research, the global Biosimilar Monoclonal Antibodies market looks promising in the next 5 years. As of 2022, the global Biosimilar Monoclonal Antibodies market was estimated at USD 5156.19 million, and it's anticipated to reach USD 14274.14 million in 2028, with a CAGR of 18.5% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs